LifeMine Therapeutics

United States
Primghar, Iowa, United States, 02140

Company profile

LifeMine Therapeutics company profile

LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines. LifeMine’s Avatar-Rx platform integrates high-throughput microbiology, data science and machine learning, genome engineering, and automation technologies to search the fungal biosphere for novel GEMs having a predetermined target and biological function. The platform integrates chemoinformatic-assisted drug optimization and state-of-the-art chemical synthesis with biotransformation to advance new product candidates into development. Founded by Gregory Verdine, PhD, Rick Klausner, MD, and WeiQing Zhou, MBA. LifeMine Therapeutics is headquartered in Cambridge, Massachusetts.

Business identity

Contact email
[email protected]
Phone number
617.665.5000
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Founded
2016-01-01, Year

Headquarters

Postal code
02140
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
3
Total equity funding
$295M
Last funding
Series C / $175M / 2022-03-23
Last equity funding
Series C / $175M
Investors
14
Lead investors
4
Founders
4
Articles
38

Founders and investors

Founders

Greg VerdineHingge HsuRick KlausnerWeiqing Zhou

Lead investors

FidelityGoogle VenturesRick KlausnerWuXi Healthcare Ventures

Investors

ARCH Venture PartnersFidelityForesite CapitalGoogle VenturesInvus